Latest Breaking News On - Parent project muscular dystrophy - Page 17 : comparemela.com

Parent Project Muscular Dystrophy Announces Pediatric Certified Duchenne Care Center, Phoenix Children s

/PRNewswire/ Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced.

United statesNew mexicoRachel schraderCertified duchenne care center programCertified duchenne care centerDuchenne organization expands certification of clinicsBarrow neurological institute at phoenix childrenProvide optimal careDuchenne muscular dystrophyParent project muscular dystrophyPhoenix childrenClinical careSaunder bernesBarrow neurological instituteDuchenne care center programProject muscular dystrophy

Myosana Therapeutics Raises $5 Million in Seed Funding

Myosana Therapeutics Raises $5 Million in Seed Funding - read this article along with other careers information, tips and advice on BioSpace

Matthew lumleyStan froehnerBiologics cdmo aldevronJohn ballantyneNick whiteheadMuscular dystrophy associationMyosana therapeutics incUniversity of washingtonRare disease clinical development at modernaParent project muscular dystrophyCureduchenne venturesVenture partnerSenior directorRare disease clinical developmentMedical directorRare diseases

UW biotech spinout raises $5M to develop gene therapy system for muscular dystrophy

UW biotech spinout raises $5M to develop gene therapy system for muscular dystrophy
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Matthew lumleyJohn ballantyneNick whiteheadStanley froehnerAgathos biologicsMuscular dystrophy associationUniversity of washingtonDrug administrationMyosana therapeuticsCo founders stanley froehnerLondon based lumleySarepta therapeuticsFargo based agathos biologicsParent project muscular dystrophyDuchenne ventures

Parent Project Muscular Dystrophy Invests $500,000 in Myosana Therapeutics to Advance Non-Viral Gene Therapy Platform

/PRNewswire/ Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today.

District of columbiaUnited statesMyosana therapeutics incResearch strategyWhich facilitated crucial dataProject muscular dystrophyMyosana therapeuticsVenture philanthropyParent project muscular dystrophyParent project muscular dystrophy ppmd

Myosana Therapeutics Raises $5M in Seed Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Matthew lumleyStan froehnerJohn ballantyneNick whiteheadMuscular dystrophy associationUniversity of washingtonMyosana therapeuticsParent project muscular dystrophyCureduchenne ventures